Latest Breaking News On - Versa therapeutics - Page 7 : comparemela.com

ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes

ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dave schemeliaCasey mcdonaldStephenc gloverZyversa therapeutics incSecurities exchangeAlternative therapiesVersa therapeuticsBetween plasmaDiabetic nephropathyPatients with typeZyversa therapeuticsCholesterol efflux mediatorSecurities exchange actPrivate securities litigation reform act

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday s Mid-Day Session - Altisource Asset Mgmt (AMEX:AAMC), AbbVie (NYSE:ABBV)

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.

Aersale corporationSemtech corporationNikola corporationFitell corporationJetblue airways corporationAlphabet incRed cat holdings incMethode electronics incSiyata mobile incNitrousink ltdCyngn incLufthansa groupCerevel therapeutics holdings incBrother limitedAltimmune incGroup limited

ZyVersa Therapeutics Announces Publication Showing AIM2 and

ZyVersa Therapeutics Announces Publication Showing AIM2 and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Dave schemeliaCasey mcdonaldStephenc gloverZyversa therapeutics incSecurities exchangeVersa therapeuticsZyversa therapeuticsCholesterol efflux mediatorSecurities exchange actPrivate securities litigation reform act

ZyVersa Therapeutics, Inc Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock

ZyVersa Therapeutics, Inc Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Casey mcdonaldDave schemeliaZyversa therapeutics incCompany annual meeting of stockholdersExchange commission onContinental stock trust companySecurities exchangeTiberend strategic advisors incVersa therapeuticsAnnual meetingEastern timeNasdaq global marketEffective timeContinental stockTrust companyExchange commission

ZyVersa Therapeutics, Inc Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock

WESTON, Fla., Nov. 30, 2023 ZyVersa Therapeutics, Inc. , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases.

Casey mcdonaldDave schemeliaTiberend strategic advisors incSecurities exchangeZyversa therapeutics incCompany annual meeting of stockholdersExchange commission onContinental stock trust companyVersa therapeuticsAnnual meetingEastern timeNasdaq global marketEffective timeContinental stockTrust companyExchange commission